Legislation and current developments in adverse drug reaction reporting in Mongolia: how far are we?
Abstract Monitoring adverse drug reactions is a vital issue to ensure drug safety and to protect the general public from medication-related harmful effects. In order to properly monitor drug safety, a regulatory system needs to be in place as well as an infrastructure that allows for analyzing natio...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-03-01
|
Series: | Journal of Pharmaceutical Policy and Practice |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40545-021-00298-8 |
id |
doaj-f8eef52c62f241bfb85dbf549a2cafda |
---|---|
record_format |
Article |
spelling |
doaj-f8eef52c62f241bfb85dbf549a2cafda2021-03-11T11:55:43ZengBMCJournal of Pharmaceutical Policy and Practice2052-32112021-03-011411810.1186/s40545-021-00298-8Legislation and current developments in adverse drug reaction reporting in Mongolia: how far are we?Zuzaan Zulzaga0Erdenetuya Myagmarsuren1Herman J. Woerdenbag2Eugene P. van Puijenbroek3Association of Mongolian Pharmacy ProfessionalsDepartment of Clinical Pharmacy and Management, School of Pharmacy, Mongolian National University of Medical SciencesDepartment of Pharmaceutical Technology and Biopharmacy, University of GroningenPharmacovigilance Centre LarebAbstract Monitoring adverse drug reactions is a vital issue to ensure drug safety and to protect the general public from medication-related harmful effects. In order to properly monitor drug safety, a regulatory system needs to be in place as well as an infrastructure that allows for analyzing national and international safety data. In Mongolia, adverse drug reaction (ADR) reporting activities have been implemented in the past decade. During this period, the basic structure and legal basis of an adverse drug reaction monitoring system was established. Because of the fragmented but growing healthcare system and the complexity of pharmaceutical issues in Mongolia, a sustainable process for the development of the adverse drug reaction reporting system is a key issue. The aim of this article is to disclose the Mongolian situation for the rest of the world and to share experiences on how an ADR reporting system can be developed towards a higher and more advanced level to contribute to both national and international drug safety issues. In this article, we review the features of the Mongolian health care and pharmaceutical systems, as well as the current development of the adverse drug reaction reporting system.https://doi.org/10.1186/s40545-021-00298-8Adverse drug reactionMongoliaMedicines safety |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Zuzaan Zulzaga Erdenetuya Myagmarsuren Herman J. Woerdenbag Eugene P. van Puijenbroek |
spellingShingle |
Zuzaan Zulzaga Erdenetuya Myagmarsuren Herman J. Woerdenbag Eugene P. van Puijenbroek Legislation and current developments in adverse drug reaction reporting in Mongolia: how far are we? Journal of Pharmaceutical Policy and Practice Adverse drug reaction Mongolia Medicines safety |
author_facet |
Zuzaan Zulzaga Erdenetuya Myagmarsuren Herman J. Woerdenbag Eugene P. van Puijenbroek |
author_sort |
Zuzaan Zulzaga |
title |
Legislation and current developments in adverse drug reaction reporting in Mongolia: how far are we? |
title_short |
Legislation and current developments in adverse drug reaction reporting in Mongolia: how far are we? |
title_full |
Legislation and current developments in adverse drug reaction reporting in Mongolia: how far are we? |
title_fullStr |
Legislation and current developments in adverse drug reaction reporting in Mongolia: how far are we? |
title_full_unstemmed |
Legislation and current developments in adverse drug reaction reporting in Mongolia: how far are we? |
title_sort |
legislation and current developments in adverse drug reaction reporting in mongolia: how far are we? |
publisher |
BMC |
series |
Journal of Pharmaceutical Policy and Practice |
issn |
2052-3211 |
publishDate |
2021-03-01 |
description |
Abstract Monitoring adverse drug reactions is a vital issue to ensure drug safety and to protect the general public from medication-related harmful effects. In order to properly monitor drug safety, a regulatory system needs to be in place as well as an infrastructure that allows for analyzing national and international safety data. In Mongolia, adverse drug reaction (ADR) reporting activities have been implemented in the past decade. During this period, the basic structure and legal basis of an adverse drug reaction monitoring system was established. Because of the fragmented but growing healthcare system and the complexity of pharmaceutical issues in Mongolia, a sustainable process for the development of the adverse drug reaction reporting system is a key issue. The aim of this article is to disclose the Mongolian situation for the rest of the world and to share experiences on how an ADR reporting system can be developed towards a higher and more advanced level to contribute to both national and international drug safety issues. In this article, we review the features of the Mongolian health care and pharmaceutical systems, as well as the current development of the adverse drug reaction reporting system. |
topic |
Adverse drug reaction Mongolia Medicines safety |
url |
https://doi.org/10.1186/s40545-021-00298-8 |
work_keys_str_mv |
AT zuzaanzulzaga legislationandcurrentdevelopmentsinadversedrugreactionreportinginmongoliahowfararewe AT erdenetuyamyagmarsuren legislationandcurrentdevelopmentsinadversedrugreactionreportinginmongoliahowfararewe AT hermanjwoerdenbag legislationandcurrentdevelopmentsinadversedrugreactionreportinginmongoliahowfararewe AT eugenepvanpuijenbroek legislationandcurrentdevelopmentsinadversedrugreactionreportinginmongoliahowfararewe |
_version_ |
1724225024201588736 |